Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 312

1.

Implementation of a student pharmacist-run diabetes education and management clinic in a federally qualified health center in Texas.

Simmons K, Klein M, Stevens C, Jacobson T.

Curr Pharm Teach Learn. 2019 Aug;11(8):849-852. doi: 10.1016/j.cptl.2019.04.015. Epub 2019 Apr 26.

PMID:
31227202
2.

Use of Lipoprotein(a) in clinical practice: A biomarker whose time has come. A scientific statement from the National Lipid Association.

Wilson DP, Jacobson TA, Jones PH, Koschinsky ML, McNeal CJ, Nordestgaard BG, Orringer CE.

J Clin Lipidol. 2019 May - Jun;13(3):374-392. doi: 10.1016/j.jacl.2019.04.010. Epub 2019 May 17.

PMID:
31147269
3.

The STatin Adverse Treatment Experience Survey: Experience of patients reporting side effects of statin therapy.

Jacobson TA, Cheeley MK, Jones PH, La Forge R, Maki KC, López JAG, Xiang P, Bushnell DM, Martin ML, Cohen JD.

J Clin Lipidol. 2019 May - Jun;13(3):415-424. doi: 10.1016/j.jacl.2019.04.011. Epub 2019 May 18.

PMID:
31113745
4.

2H and 13C metabolic flux analysis elucidates in vivo thermodynamics of the ED pathway in Zymomonas mobilis.

Jacobson TB, Adamczyk PA, Stevenson DM, Regner M, Ralph J, Reed JL, Amador-Noguez D.

Metab Eng. 2019 Jul;54:301-316. doi: 10.1016/j.ymben.2019.05.006. Epub 2019 May 10.

5.

Ipsilesional Mu Rhythm Desynchronization and Changes in Motor Behavior Following Post Stroke BCI Intervention for Motor Rehabilitation.

Remsik AB, Williams L Jr, Gjini K, Dodd K, Thoma J, Jacobson T, Walczak M, McMillan M, Rajan S, Young BM, Nigogosyan Z, Advani H, Mohanty R, Tellapragada N, Allen J, Mazrooyisebdani M, Walton LM, van Kan PLE, Kang TJ, Sattin JA, Nair VA, Edwards DF, Williams JC, Prabhakaran V.

Front Neurosci. 2019 Mar 6;13:53. doi: 10.3389/fnins.2019.00053. eCollection 2019.

6.

Effects of Icosapent Ethyl on Total Ischemic Events: From REDUCE-IT.

Bhatt DL, Steg PG, Miller M, Brinton EA, Jacobson TA, Ketchum SB, Doyle RT Jr, Juliano RA, Jiao L, Granowitz C, Tardif JC, Gregson J, Pocock SJ, Ballantyne CM; REDUCE-IT Investigators.

J Am Coll Cardiol. 2019 Jun 11;73(22):2791-2802. doi: 10.1016/j.jacc.2019.02.032. Epub 2019 Mar 18.

7.

Myoelectric Computer Interface Training for Reducing Co-Activation and Enhancing Arm Movement in Chronic Stroke Survivors: A Randomized Trial.

Mugler EM, Tomic G, Singh A, Hameed S, Lindberg EW, Gaide J, Alqadi M, Robinson E, Dalzotto K, Limoli C, Jacobson T, Lee J, Slutzky MW.

Neurorehabil Neural Repair. 2019 Apr;33(4):284-295. doi: 10.1177/1545968319834903. Epub 2019 Mar 19.

PMID:
30888251
8.

Statin Safety and Associated Adverse Events: A Scientific Statement From the American Heart Association.

Newman CB, Preiss D, Tobert JA, Jacobson TA, Page RL 2nd, Goldstein LB, Chin C, Tannock LR, Miller M, Raghuveer G, Duell PB, Brinton EA, Pollak A, Braun LT, Welty FK; American Heart Association Clinical Lipidology, Lipoprotein, Metabolism and Thrombosis Committee, a Joint Committee of the Council on Atherosclerosis, Thrombosis and Vascular Biology and Council on Lifestyle and Cardiometabolic Health; Council on Cardiovascular Disease in the Young; Council on Clinical Cardiology; and Stroke Council.

Arterioscler Thromb Vasc Biol. 2019 Feb;39(2):e38-e81. doi: 10.1161/ATV.0000000000000073. Erratum in: Arterioscler Thromb Vasc Biol. 2019 May;39(5):e158.

PMID:
30580575
9.

Behavioral Outcomes Following Brain-Computer Interface Intervention for Upper Extremity Rehabilitation in Stroke: A Randomized Controlled Trial.

Remsik AB, Dodd K, Williams L Jr, Thoma J, Jacobson T, Allen JD, Advani H, Mohanty R, McMillan M, Rajan S, Walczak M, Young BM, Nigogosyan Z, Rivera CA, Mazrooyisebdani M, Tellapragada N, Walton LM, Gjini K, van Kan PLE, Kang TJ, Sattin JA, Nair VA, Edwards DF, Williams JC, Prabhakaran V.

Front Neurosci. 2018 Nov 8;12:752. doi: 10.3389/fnins.2018.00752. eCollection 2018.

10.

Per- and polyfluoroalkyl substances and fluorine mass balance in cosmetic products from the Swedish market: implications for environmental emissions and human exposure.

Schultes L, Vestergren R, Volkova K, Westberg E, Jacobson T, Benskin JP.

Environ Sci Process Impacts. 2018 Dec 12;20(12):1680-1690. doi: 10.1039/c8em00368h.

PMID:
30427048
11.

Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia.

Bhatt DL, Steg PG, Miller M, Brinton EA, Jacobson TA, Ketchum SB, Doyle RT Jr, Juliano RA, Jiao L, Granowitz C, Tardif JC, Ballantyne CM; REDUCE-IT Investigators.

N Engl J Med. 2019 Jan 3;380(1):11-22. doi: 10.1056/NEJMoa1812792. Epub 2018 Nov 10.

PMID:
30415628
12.

Safety and efficacy of statin therapy.

Adhyaru BB, Jacobson TA.

Nat Rev Cardiol. 2018 Dec;15(12):757-769. doi: 10.1038/s41569-018-0098-5. Review.

PMID:
30375494
13.

Early Findings on Functional Connectivity Correlates of Behavioral Outcomes of Brain-Computer Interface Stroke Rehabilitation Using Machine Learning.

Mohanty R, Sinha AM, Remsik AB, Dodd KC, Young BM, Jacobson T, McMillan M, Thoma J, Advani H, Nair VA, Kang TJ, Caldera K, Edwards DF, Williams JC, Prabhakaran V.

Front Neurosci. 2018 Sep 11;12:624. doi: 10.3389/fnins.2018.00624. eCollection 2018.

14.

Integrating a Geneticist in a Multidisciplinary Clinic for Down Syndrome Increases Commitment to Genetic Counseling.

Santoro SL, Jacobson T, Lemle S, Bartman T.

Pediatr Qual Saf. 2017 Aug 25;2(5):e039. doi: 10.1097/pq9.0000000000000039. eCollection 2017 Sep-Oct.

15.
16.

Optimizing biomass estimates of savanna woodland at different spatial scales in the Brazilian Cerrado: Re-evaluating allometric equations and environmental influences.

Roitman I, Bustamante MMC, Haidar RF, Shimbo JZ, Abdala GC, Eiten G, Fagg CW, Felfili MC, Felfili JM, Jacobson TKB, Lindoso GS, Keller M, Lenza E, Miranda SC, Pinto JRR, Rodrigues AA, Delitti WBC, Roitman P, Sampaio JM.

PLoS One. 2018 Aug 1;13(8):e0196742. doi: 10.1371/journal.pone.0196742. eCollection 2018.

17.

Machine Learning Classification to Identify the Stage of Brain-Computer Interface Therapy for Stroke Rehabilitation Using Functional Connectivity.

Mohanty R, Sinha AM, Remsik AB, Dodd KC, Young BM, Jacobson T, McMillan M, Thoma J, Advani H, Nair VA, Kang TJ, Caldera K, Edwards DF, Williams JC, Prabhakaran V.

Front Neurosci. 2018 May 29;12:353. doi: 10.3389/fnins.2018.00353. eCollection 2018.

18.

Adverse effects of statin therapy: perception vs. the evidence - focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract.

Mach F, Ray KK, Wiklund O, Corsini A, Catapano AL, Bruckert E, De Backer G, Hegele RA, Hovingh GK, Jacobson TA, Krauss RM, Laufs U, Leiter LA, März W, Nordestgaard BG, Raal FJ, Roden M, Santos RD, Stein EA, Stroes ES, Thompson PD, Tokgözoglu L, Vladutiu GD, Gencer B, Stock JK, Ginsberg HN, Chapman MJ; European Atherosclerosis Society Consensus Panel.

Eur Heart J. 2018 Jul 14;39(27):2526-2539. doi: 10.1093/eurheartj/ehy182.

19.

Persistence of Coffea arabica and its relationship with the structure, species diversity and composition of a secondary forest in Brazil.

Raymundo D, Prado-Junior J, de Oliveira-Neto NE, Santana LD, do Vale VS, Jacobson TB, de Oliveira PEAM, Carvalho FA.

PLoS One. 2018 Mar 14;13(3):e0194032. doi: 10.1371/journal.pone.0194032. eCollection 2018.

20.

Transferring Exome Sequencing Data from Clinical Laboratories to Healthcare Providers: Lessons Learned at a Pediatric Hospital.

Swaminathan R, Huang Y, Miller K, Pastore M, Hashimoto S, Jacobson T, Mouhlas D, Lin S.

Front Genet. 2018 Feb 21;9:54. doi: 10.3389/fgene.2018.00054. eCollection 2018.

21.

A rapidly expanding Bose-Einstein condensate: an expanding universe in the lab.

Eckel S, Kumar A, Jacobson T, Spielman IB, Campbell GK.

Phys Rev X. 2018;8. doi: 10.1103/PhysRevX.8.021021.

22.

Provider recommendations for patient-reported muscle symptoms on statin therapy: Insights from the Understanding Statin Use in America and Gaps in Patient Education survey.

Jacobson TA, Khan A, Maki KC, Brinton EA, Cohen JD.

J Clin Lipidol. 2018 Jan - Feb;12(1):78-88. doi: 10.1016/j.jacl.2017.09.006. Epub 2017 Oct 12.

23.

Metabolome analysis reveals a role for glyceraldehyde 3-phosphate dehydrogenase in the inhibition of C. thermocellum by ethanol.

Tian L, Perot SJ, Stevenson D, Jacobson T, Lanahan AA, Amador-Noguez D, Olson DG, Lynd LR.

Biotechnol Biofuels. 2017 Nov 30;10:276. doi: 10.1186/s13068-017-0961-3. eCollection 2017.

24.

Unblinded ASCOT study results do not rule out that muscle symptoms are an adverse effect of statins.

Adhyaru BB, Jacobson TA.

Evid Based Med. 2017 Dec;22(6):210. doi: 10.1136/ebmed-2017-110783. Epub 2017 Oct 22. Review. No abstract available.

PMID:
29056606
25.

Application of the Statin-Associated Muscle Symptoms-Clinical Index to a Randomized Trial on Statin Myopathy.

Taylor BA, Sanchez RJ, Jacobson TA, Chibedi-De-Roche D, Manvelian G, Baccara-Dinet MT, Khan I, Rosenson RS.

J Am Coll Cardiol. 2017 Sep 26;70(13):1680-1681. doi: 10.1016/j.jacc.2017.07.767. No abstract available.

26.

The effect of a perioperative ketamine infusion on the incidence of chronic postsurgical pain-a pilot study.

Peyton PJ, Wu C, Jacobson T, Hogg M, Zia F, Leslie K.

Anaesth Intensive Care. 2017 Jul;45(4):459-465.

27.

Cadmium Causes Misfolding and Aggregation of Cytosolic Proteins in Yeast.

Jacobson T, Priya S, Sharma SK, Andersson S, Jakobsson S, Tanghe R, Ashouri A, Rauch S, Goloubinoff P, Christen P, Tamás MJ.

Mol Cell Biol. 2017 Aug 11;37(17). pii: e00490-16. doi: 10.1128/MCB.00490-16. Print 2017 Sep 1.

28.

Barriers to PCSK9 inhibitor prescriptions for patients with high cardiovascular risk: Results of a healthcare provider survey conducted by the National Lipid Association.

Cohen JD, Cziraky MJ, Jacobson TA, Maki KC, Karalis DG.

J Clin Lipidol. 2017 Jul - Aug;11(4):891-900. doi: 10.1016/j.jacl.2017.04.120. Epub 2017 May 24.

29.

Update on the use of PCSK9 inhibitors in adults: Recommendations from an Expert Panel of the National Lipid Association.

Orringer CE, Jacobson TA, Saseen JJ, Brown AS, Gotto AM, Ross JL, Underberg JA.

J Clin Lipidol. 2017 Jul - Aug;11(4):880-890. doi: 10.1016/j.jacl.2017.05.001. Epub 2017 May 19.

30.

Role of Non-Statins, LDL-C Thresholds, and Special Population Considerations: A Look at the Updated 2016 ACC Consensus Committee Recommendations.

Adhyaru BB, Jacobson TA.

Curr Atheroscler Rep. 2017 Jun;19(6):29. doi: 10.1007/s11883-017-0666-x. Review.

PMID:
28500517
31.

The Statin-Associated Muscle Symptom Clinical Index (SAMS-CI): Revision for Clinical Use, Content Validation, and Inter-rater Reliability.

Rosenson RS, Miller K, Bayliss M, Sanchez RJ, Baccara-Dinet MT, Chibedi-De-Roche D, Taylor B, Khan I, Manvelian G, White M, Jacobson TA.

Cardiovasc Drugs Ther. 2017 Apr;31(2):179-186. doi: 10.1007/s10557-017-6723-4.

32.

Unification of de novo and acquired ibrutinib resistance in mantle cell lymphoma.

Zhao X, Lwin T, Silva A, Shah B, Tao J, Fang B, Zhang L, Fu K, Bi C, Li J, Jiang H, Meads MB, Jacobson T, Silva M, Distler A, Darville L, Zhang L, Han Y, Rebatchouk D, Di Liberto M, Moscinski LC, Koomen JM, Dalton WS, Shain KH, Wang M, Sotomayor E, Tao J.

Nat Commun. 2017 Apr 18;8:14920. doi: 10.1038/ncomms14920.

33.

An Ex Vivo Platform for the Prediction of Clinical Response in Multiple Myeloma.

Silva A, Silva MC, Sudalagunta P, Distler A, Jacobson T, Collins A, Nguyen T, Song J, Chen DT, Chen L, Cubitt C, Baz R, Perez L, Rebatchouk D, Dalton W, Greene J, Gatenby R, Gillies R, Sontag E, Meads MB, Shain KH.

Cancer Res. 2017 Jun 15;77(12):3336-3351. doi: 10.1158/0008-5472.CAN-17-0502. Epub 2017 Apr 11.

34.

Rationale and design of REDUCE-IT: Reduction of Cardiovascular Events with Icosapent Ethyl-Intervention Trial.

Bhatt DL, Steg PG, Brinton EA, Jacobson TA, Miller M, Tardif JC, Ketchum SB, Doyle RT Jr, Murphy SA, Soni PN, Braeckman RA, Juliano RA, Ballantyne CM; REDUCE-IT Investigators.

Clin Cardiol. 2017 Mar;40(3):138-148. doi: 10.1002/clc.22692. Epub 2017 Mar 15.

35.

Omega-3 Polyunsaturated Fatty Acid (Fish Oil) Supplementation and the Prevention of Clinical Cardiovascular Disease: A Science Advisory From the American Heart Association.

Siscovick DS, Barringer TA, Fretts AM, Wu JH, Lichtenstein AH, Costello RB, Kris-Etherton PM, Jacobson TA, Engler MB, Alger HM, Appel LJ, Mozaffarian D; American Heart Association Nutrition Committee of the Council on Lifestyle and Cardiometabolic Health; Council on Epidemiology and Prevention; Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; and Council on Clinical Cardiology.

Circulation. 2017 Apr 11;135(15):e867-e884. doi: 10.1161/CIR.0000000000000482. Epub 2017 Mar 13. Review.

PMID:
28289069
36.

Development and Content Validity of the Statin Experience Assessment Questionnaire (SEAQ)©.

Jacobson TA, Edelman SV, Galipeau N, Shields AL, Mallya UG, Koren A, Davidson MH.

Patient. 2017 Jun;10(3):321-334. doi: 10.1007/s40271-016-0211-y.

37.

Single neuron activity and theta modulation in the posterior parietal cortex in a visuospatial attention task.

Yang FC, Jacobson TK, Burwell RD.

Hippocampus. 2017 Mar;27(3):263-273. doi: 10.1002/hipo.22691. Epub 2017 Feb 2.

38.

Cybersecurity in healthcare: A systematic review of modern threats and trends.

Kruse CS, Frederick B, Jacobson T, Monticone DK.

Technol Health Care. 2017;25(1):1-10. doi: 10.3233/THC-161263. Review.

PMID:
27689562
39.

Metabolic syndrome is associated with muscle symptoms among statin users.

Brinton EA, Maki KC, Jacobson TA, Sponseller CA, Cohen JD.

J Clin Lipidol. 2016 Jul-Aug;10(4):1022-1029. doi: 10.1016/j.jacl.2016.05.003. Epub 2016 May 17.

PMID:
27578135
40.

Gender differences in side effects and attitudes regarding statin use in the Understanding Statin Use in America and Gaps in Patient Education (USAGE) study.

Karalis DG, Wild RA, Maki KC, Gaskins R, Jacobson TA, Sponseller CA, Cohen JD.

J Clin Lipidol. 2016 Jul-Aug;10(4):833-841. doi: 10.1016/j.jacl.2016.02.016. Epub 2016 Mar 14.

PMID:
27578114
41.

Erratum to: Efficacy and Safety of the PCSK9 Inhibitor Evolocumab in Patients with Mixed Hyperlipidemia.

Rosenson RS, Jacobson TA, Preiss D, Djedjos SC, Dent R, Bridges I, Miller M.

Cardiovasc Drugs Ther. 2016 Oct;30(5):537. No abstract available.

PMID:
27497929
42.

Entanglement Equilibrium and the Einstein Equation.

Jacobson T.

Phys Rev Lett. 2016 May 20;116(20):201101. doi: 10.1103/PhysRevLett.116.201101. Epub 2016 May 20.

PMID:
27258860
43.

Efficacy and Safety of the PCSK9 Inhibitor Evolocumab in Patients with Mixed Hyperlipidemia.

Rosenson RS, Jacobson TA, Preiss D, Djedjos CS, Dent R, Bridges I, Miller M.

Cardiovasc Drugs Ther. 2016 Jun;30(3):305-13. doi: 10.1007/s10557-016-6666-1. Erratum in: Cardiovasc Drugs Ther. 2016 Oct;30(5):537.

44.

Lipids and bariatric procedures Part 2 of 2: scientific statement from the American Society for Metabolic and Bariatric Surgery (ASMBS), the National Lipid Association (NLA), and Obesity Medicine Association (OMA).

Bays H, Kothari SN, Azagury DE, Morton JM, Nguyen NT, Jones PH, Jacobson TA, Cohen DE, Orringer C, Westman EC, Horn DB, Scinta W, Primack C.

Surg Obes Relat Dis. 2016 Mar-Apr;12(3):468-495. doi: 10.1016/j.soard.2016.01.007. Epub 2016 Jan 12. Review.

PMID:
27050404
46.

Lipids and bariatric procedures part 1 of 2: Scientific statement from the National Lipid Association, American Society for Metabolic and Bariatric Surgery, and Obesity Medicine Association: FULL REPORT.

Bays HE, Jones PH, Jacobson TA, Cohen DE, Orringer CE, Kothari S, Azagury DE, Morton J, Nguyen NT, Westman EC, Horn DB, Scinta W, Primack C.

J Clin Lipidol. 2016 Jan-Feb;10(1):33-57. doi: 10.1016/j.jacl.2015.12.002. Epub 2015 Dec 22.

PMID:
26892120
47.

Lipids and bariatric procedures part 1 of 2: Scientific statement from the National Lipid Association, American Society for Metabolic and Bariatric Surgery, and Obesity Medicine Association: EXECUTIVE SUMMARY.

Bays HE, Jones PH, Jacobson TA, Cohen DE, Orringer CE, Kothari S, Azagury DE, Morton J, Nguyen NT, Westman EC, Horn DB, Scinta W, Primack C.

J Clin Lipidol. 2016 Jan-Feb;10(1):15-32. doi: 10.1016/j.jacl.2015.12.003. Epub 2015 Dec 22.

PMID:
26892119
48.

National Lipid Association Annual Summary of Clinical Lipidology 2016.

Bays HE, Jones PH, Orringer CE, Brown WV, Jacobson TA.

J Clin Lipidol. 2016 Jan-Feb;10(1 Suppl):S1-43. doi: 10.1016/j.jacl.2015.08.002. Review.

PMID:
26891998
49.

Mutations in the nuclear bile acid receptor FXR cause progressive familial intrahepatic cholestasis.

Gomez-Ospina N, Potter CJ, Xiao R, Manickam K, Kim MS, Kim KH, Shneider BL, Picarsic JL, Jacobson TA, Zhang J, He W, Liu P, Knisely AS, Finegold MJ, Muzny DM, Boerwinkle E, Lupski JR, Plon SE, Gibbs RA, Eng CM, Yang Y, Washington GC, Porteus MH, Berquist WE, Kambham N, Singh RJ, Xia F, Enns GM, Moore DD.

Nat Commun. 2016 Feb 18;7:10713. doi: 10.1038/ncomms10713.

50.

Effect of Pharmacist Counseling Intervention on Health Care Utilization Following Hospital Discharge: A Randomized Control Trial.

Bell SP, Schnipper JL, Goggins K, Bian A, Shintani A, Roumie CL, Dalal AK, Jacobson TA, Rask KJ, Vaccarino V, Gandhi TK, Labonville SA, Johnson D, Neal EB, Kripalani S; Pharmacist Intervention for Low Literacy in Cardiovascular Disease (PILL-CVD) Study Group.

J Gen Intern Med. 2016 May;31(5):470-7. doi: 10.1007/s11606-016-3596-3.

Supplemental Content

Loading ...
Support Center